CINECA IRIS Institutional Research Information System

ZAGGIA, Barbara
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.584
EU - Europa 2.243
AS - Asia 1.011
SA - Sud America 140
AF - Africa 66
OC - Oceania 43
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.088
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.513
IT - Italia 596
CN - Cina 365
DE - Germania 297
FR - Francia 230
SE - Svezia 179
SG - Singapore 160
IE - Irlanda 134
JP - Giappone 123
UA - Ucraina 117
FI - Finlandia 103
AT - Austria 94
GB - Regno Unito 86
IN - India 77
PL - Polonia 73
BR - Brasile 69
KR - Corea 69
ES - Italia 63
NL - Olanda 59
CA - Canada 48
GR - Grecia 41
SN - Senegal 41
AR - Argentina 38
AU - Australia 38
VN - Vietnam 38
RU - Federazione Russa 35
TR - Turchia 35
HK - Hong Kong 24
CH - Svizzera 22
MX - Messico 21
TW - Taiwan 19
CO - Colombia 17
IL - Israele 17
PT - Portogallo 17
ID - Indonesia 15
BE - Belgio 14
TH - Thailandia 13
CZ - Repubblica Ceca 12
HR - Croazia 12
CL - Cile 11
DZ - Algeria 10
IR - Iran 10
SA - Arabia Saudita 9
RS - Serbia 8
DK - Danimarca 7
HU - Ungheria 7
SI - Slovenia 7
SY - Repubblica araba siriana 7
MY - Malesia 6
BG - Bulgaria 5
NZ - Nuova Zelanda 5
PH - Filippine 5
PK - Pakistan 5
RO - Romania 5
BA - Bosnia-Erzegovina 4
CD - Congo 4
PE - Perù 4
SK - Slovacchia (Repubblica Slovacca) 4
BY - Bielorussia 3
IQ - Iraq 3
ZA - Sudafrica 3
EE - Estonia 2
EG - Egitto 2
JO - Giordania 2
KE - Kenya 2
NO - Norvegia 2
NP - Nepal 2
RE - Reunion 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BD - Bangladesh 1
CU - Cuba 1
EU - Europa 1
IM - Isola di Man 1
JM - Giamaica 1
KG - Kirghizistan 1
KH - Cambogia 1
LB - Libano 1
LT - Lituania 1
MC - Monaco 1
MT - Malta 1
MU - Mauritius 1
PS - Palestinian Territory 1
TN - Tunisia 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 6.088
Salva come PNG Salva come JPEG
Città #
Chandler 280
Beijing 164
Singapore 132
Dublin 127
Santa Clara 124
Fairfield 123
Houston 123
Ashburn 117
Redwood City 111
Vienna 88
Wilmington 88
Torino 86
Woodbridge 83
Seattle 66
Nyköping 65
Cambridge 61
Ann Arbor 55
Medford 53
Villeurbanne 52
Warsaw 49
Dearborn 45
Jacksonville 44
Pisa 42
Princeton 41
Milan 40
Columbus 37
Würzburg 36
Tokyo 28
Buenos Aires 27
Fremont 27
Shanghai 27
Turin 27
Munich 25
Brescia 23
Düsseldorf 22
Guangzhou 22
Dong Ket 21
Paris 21
Amsterdam 20
Bethesda 19
Rome 19
Los Angeles 18
Padova 18
Athens 16
Chengdu 16
Nanjing 16
Ankara 15
Jakarta 15
São Paulo 15
Florence 12
New York 12
Pune 12
Taipei 12
London 11
Madrid 11
Zhengzhou 11
Bogotá 10
San Diego 10
Santiago 10
Barcelona 9
Boston 9
Brussels 9
Chicago 9
Dallas 9
Fontenay-sous-bois 9
Lyon 9
Moscow 9
Brisbane 8
Canberra 8
Helsinki 8
Hong Kong 8
Memphis 8
Naples 8
Rochester 8
Roubaix 8
Shenyang 8
Mont-saint-aignan 7
Phoenix 7
Pittsburgh 7
Recife 7
Washington 7
Bangkok 6
Birmingham 6
Boardman 6
Brno 6
Delhi 6
Polska 6
Québec 6
Schwelm 6
Seoul 6
Zagreb 6
Central District 5
Fuzhou 5
Garza García 5
Istanbul 5
Ljubljana 5
Mumbai 5
Nesher 5
Osaka 5
Portland 5
Totale 3.184
Salva come PNG Salva come JPEG
Nome #
Practical treatment using mitotane for adrenocortical carcinoma. 761
Validation of the prognostic role of the "Helsinki Score" in 225 cases of adrenocortical carcinoma 712
Prognostic factors in stage III-IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study. 506
Management of adrenal cancer: a 2013 update. 457
Management of adjuvant mitotane therapy following resection of adrenal cancer. 330
18F-FDG PET/CT in the post-operative monitoring of patients with adrenocortical carcinoma. 327
Effects of mitotane on the hypothalamic-pituitary-adrenal axis in patients with adrenocortical carcinoma 265
Topoisomerase 2α and thymidylate synthase expression in adrenocortical cancer 219
Diagnosi e terapia del carcinoma corticosurrenalico 182
Retrospective evaluation of the outcome of open versus laparoscopic adrenalectomy for stage I and II adrenocortical cancer. 160
Efficacia del reintervento chirurgico in pazienti con carcinoma del cortico-surrene recidivo 120
La recidiva di carcinoma del cortico-surrene:trattamento chirurgico o chemioterapico? 117
Evaluation of cardiovascular risk factors in patients with incidentally discovered adrenal adenoma during a follow-up longer than five years 114
Valutazione prospettica di pazienti operati radicalmente per carcinoma corticosurrenalico in trattamento con mitotane adiuvante: correlazioni tra indici di massa corporea, livelli di mitotanemia ed efficacia. 110
Efficacy of repeat surgery in patients with recurrent adrenocortical cancer (ACC) 109
A prospective study on adjuvant mitotane 103
Evaluation of Cardiovascular Risk Factors in Patients with Incidentally Discovered Adrenal Adenoma during a Follow-Up Longer Than Five Years. 98
The San Luigi hospital experience with adjuvant mitotane treatment in patients with adrenocortical cancer following radical resection 97
Epidemiology of acromegaly in Italy 96
Carcinoma del cortico surrene: chirurgia open o laparoscopia? 93
Does nephrectomy during adrenalectomy for adrenal cancer improve oncological results? 91
L'esperienza dell'ospedale san Luigi nel trattamento con mitotane adiuvante in pazienti operati radicalmente per carcinoma corticosurrenalico. 86
LA Nefrectomia in corso di surrenectomia radicale per carcinoma Corticosurrenalico modifica i risultati oncologici? 85
Influence of the CYP2B6 polymorphism on the pharmacokinetics of mitotane. 81
The combined low-dose dexamethasone suppression corticotropin-releasing hormone test as a tool to rule out Cushing's syndrome 77
Efficacia del reintervento chirurgico in pazienti con carcinoma del cortico-surrene recidivo 76
Comparison of 1-mg versus 8-mg dexamethasone suppression test (DST) in patients with clinically inapparent adrenal adenoma 75
Midnight salivary cortisol for diagnosis of subclinical Cushing’s syndrome in patients with clinically inapparent adrenocortical adenoma. 72
Prospective evaluation of mitotane toxicity in adrenocortical cancer patients treated adjuvantly 71
Pitfalls in the diagnosis of adrenocortical tumors: A lesson from 300 consultation cases 71
Demographic Data, Co-Morbidities, Malignancies and Mortality from the First Large-Scale Italian Study on Acromegaly. 71
Mitotane 67
Gemcitabine plus metronomic 5-fluorouracil or capecitabine as a second-/third-line chemotherapy in advanced adrenocortical carcinoma: a multicenter phase II study. 67
Does nephrectomy during radical adrenalectomy for stage II adrenocortical cancer affect patient outcome? 63
THE ROLE OF SURGERY IN THE MANAGEMENT OF RECURRENT ADRENOCORTICAL CARCINOMA: RESULTS OF A RETROSPECTIVE STUDY 59
Rapporto tra acromegalia e neoplasia: fantasia o realtà? 59
Mitotane treatment for adrenocortical carcinoma: an overview. 58
null 40
Efficacy of repeat surgery in patients with recurrent adrenocortical cancer 38
“Mitotane” in Adrenocortical Carcinoma, Basic Science and Clinical Concepts 9
Totale 6.292
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.979
article - articoli 0
book - libri 0
conference - conferenze 5.518
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.497
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020570 0 0 0 0 0 133 95 77 90 79 53 43
2020/2021684 75 50 53 42 64 66 75 38 44 74 46 57
2021/2022657 27 32 25 62 52 24 47 42 26 67 151 102
2022/2023885 90 85 27 111 64 195 50 60 93 15 53 42
2023/2024487 61 62 35 25 37 70 31 27 7 36 48 48
2024/2025530 36 35 40 80 242 97 0 0 0 0 0 0
Totale 6.292